GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q3 2014. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $141,807,000 | +44.4% | 653,789 | -23.2% | 0.02% | +40.0% |
| Q4 2020 | $98,193,000 | +21.4% | 850,825 | +2.4% | 0.02% | -6.2% |
| Q3 2020 | $80,856,000 | -15.4% | 830,565 | +6.6% | 0.02% | -23.8% |
| Q2 2020 | $95,596,000 | +36.4% | 778,977 | -2.7% | 0.02% | +10.5% |
| Q1 2020 | $70,079,000 | -24.8% | 800,265 | -10.2% | 0.02% | -13.6% |
| Q4 2019 | $93,225,000 | -2.8% | 891,595 | +7.0% | 0.02% | -12.0% |
| Q3 2019 | $95,863,000 | +8.1% | 833,371 | +61.9% | 0.02% | +4.2% |
| Q2 2019 | $88,717,000 | +21.5% | 514,627 | +18.8% | 0.02% | +14.3% |
| Q1 2019 | $73,032,000 | +35.4% | 433,247 | -21.8% | 0.02% | +31.2% |
| Q4 2018 | $53,943,000 | -27.7% | 553,883 | +28.2% | 0.02% | -15.8% |
| Q3 2018 | $74,649,000 | +41.2% | 432,144 | +14.1% | 0.02% | +35.7% |
| Q2 2018 | $52,855,000 | +36.0% | 378,776 | +9.8% | 0.01% | +27.3% |
| Q1 2018 | $38,871,000 | -23.6% | 344,992 | -10.5% | 0.01% | -21.4% |
| Q4 2017 | $50,864,000 | +94.1% | 385,299 | +49.2% | 0.01% | +75.0% |
| Q3 2017 | $26,202,000 | -11.0% | 258,177 | -12.1% | 0.01% | -11.1% |
| Q2 2017 | $29,451,000 | -59.6% | 293,776 | -51.3% | 0.01% | -18.2% |
| Q1 2017 | $72,922,000 | +27.3% | 602,944 | +17.6% | 0.01% | +22.2% |
| Q4 2016 | $57,296,000 | +82.0% | 512,722 | +116.2% | 0.01% | -18.2% |
| Q3 2016 | $31,478,000 | +149.9% | 237,156 | +72.4% | 0.01% | +120.0% |
| Q2 2016 | $12,596,000 | +35.6% | 137,556 | +6.8% | 0.01% | +25.0% |
| Q1 2016 | $9,291,000 | +42.9% | 128,765 | +37.5% | 0.00% | +100.0% |
| Q4 2015 | $6,502,000 | -38.1% | 93,630 | -18.6% | 0.00% | -50.0% |
| Q3 2015 | $10,510,000 | -28.8% | 115,024 | -4.3% | 0.00% | -20.0% |
| Q2 2015 | $14,758,000 | +123.2% | 120,137 | +65.6% | 0.01% | +150.0% |
| Q1 2015 | $6,612,000 | -22.2% | 72,555 | -42.2% | 0.00% | -33.3% |
| Q4 2014 | $8,495,000 | -54.6% | 125,526 | -45.8% | 0.00% | -57.1% |
| Q3 2014 | $18,711,000 | -30.8% | 231,424 | -8.2% | 0.01% | -36.4% |
| Q2 2014 | $27,044,000 | +111.4% | 252,062 | +17.0% | 0.01% | +120.0% |
| Q1 2014 | $12,790,000 | +339.7% | 215,440 | +207.6% | 0.01% | +400.0% |
| Q4 2013 | $2,909,000 | – | 70,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |